tirzepatide-weight management 2.5 mg/0.5ml solution auto-injector Tirzepatide Weight Loss Injections • Fit 4 Life Weight Loss Medical Center Mounjaro

Standard cycles run 12-16 weeks

Faerch K, Torekov SS, Vistisen D et al (2015) GLP-1 response to oral glucose is reduced in prediabetes, screen-detected type 2 diabetes, and obesity and influenced by sex: the ADDITION-PRO study

methodology, F.P

Massive obesity market opportunity Growing diabetes prevalence globally Potential cardiovascular benefits Expanding applications beyond weight loss Strong commercial performance from current market leaders The success of Ozempic, Wegovy, Mounjaro, and Zepbound has demonstrated that obesity treatment is no longer a niche categoryit is becoming one of the most important therapeutic areas in modern medicine

Results vary and depend on lifestyle, nutrition and consistency

The 5 UTR, however, does not allow sufficient discrimination between closely related subtypes within the same genotype